NCT00383994 2019-07-31Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell TransplantationM.D. Anderson Cancer CenterPhase 1 Completed6 enrolled